Evaluating the efficacy of EFTX ASO in inhibiting the most prevalent lung cancer KRAS mutations (2021)
Undergraduates: Jonah Im, Jonah Im, Hayden Huggins, Salma Azam, and Chad Pecot.
Link to Poster Link to Presentation
You must be logged in to post a comment.